8
Clinical Trials associated with TS-172A Phase 1, Open-label, Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
A phase 1, open-label, pharmacokinetic study of TS-172 in patients on hemodialysis
A Drug-drug Interaction Study with TS-172 in Healthy Adult Male Subjects
An open-label, single-center, single-sequence study to evaluate the drug-drud interaction between the CYP3A substrate triazolam and TS-172 (part A) and the potent CYP3A inhibitor itraconazole and TS-172 (part B) in healthy male subjects on their pharmacokinetics, safety and tolerability
A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects
A clinical study to evaluate the effects on QT/QTc interval of TS-172 in healthy adults subjects
100 Clinical Results associated with TS-172
100 Translational Medicine associated with TS-172
100 Patents (Medical) associated with TS-172
100 Deals associated with TS-172